Istesso: Hambro SPAC ditches merger talks with biotech firm

Hambro Perks Acquisition Company (HPAC), a pioneering special purpose acquisition company (SPAC), has abandoned plans for a merger with biotech firm Istesso. HPAC, which became the first SPAC to float in London in November 2021 after regulators overhauled UK rules, had been in talks with Istesso over a planned merger. Istesso is part-owned by London-listed [...]The post Hambro SPAC ditches merger talks with biotech firm appeared first on CityAM.